Related Experiment Videos

[Research progress of metabolomics in the pathogenesis and treatment of constipation in children]

Xiao-Long Chen1, Mi-Zu Jiang

  • 1Department of Gastroenterology and Pediatric Endoscopy Center, Children's Hospital, Zhejiang University School of Medicine/National Clinical Research Center for Child Health/National Children's Regional Medical Center, Hangzhou 310052, China.

Insights

Metabolomics research reveals key metabolic changes in pediatric constipation, offering insights into its causes and potential targets for personalized treatments. This approach enhances understanding beyond traditional methods.

Area of Science:

  • Pediatric functional gastrointestinal disorders
  • Systems biology applications in medicine
  • Metabolomics and disease research

Background:

  • Pediatric constipation is a prevalent functional gastrointestinal disorder impacting children's quality of life.
  • Traditional research methods face challenges in fully understanding constipation's complex causes and individual differences.
  • Metabolomics offers a powerful tool for systematic analysis of metabolites in disease research.

Purpose of the Study:

  • To review the application of metabolomics in pediatric constipation research.
  • To summarize characteristic metabolite profile changes and regulatory mechanisms in pediatric constipation.
  • To evaluate potential pathogenic mechanisms and therapeutic targets for individualized treatment.

Main Methods:

  • Systematic review of metabolomics studies in pediatric constipation.
  • Analysis of metabolite profiles and metabolic pathway regulation.
  • Evaluation of pathogenic mechanisms and therapeutic targets based on metabolomic data.

Main Results:

  • Metabolomics identifies specific metabolite alterations in children with constipation.
  • Changes in metabolic pathways provide insights into the pathophysiology of pediatric constipation.
  • This approach highlights potential targets for novel therapeutic strategies.

Conclusions:

  • Metabolomics provides a comprehensive understanding of pediatric constipation's etiology.
  • Metabolomic findings can guide the development of individualized treatment plans.
  • Future research directions include further validation and clinical application of metabolomic discoveries.

Related Concept Videos

Drugs for Treatment of Constipation-Predominant IBS01:21

Drugs for Treatment of Constipation-Predominant IBS

Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
Imaging Studies III: Gastrointestinal Motility Studies and Virtual Colonoscopy01:26

Imaging Studies III: Gastrointestinal Motility Studies and Virtual Colonoscopy

This lesson explores three gastrointestinal imaging techniques: radionuclide testing, colonic transit studies, and virtual colonoscopy.
Radionuclide Testing
Radionuclide testing is a sophisticated medical technique for assessing gastrointestinal motility. It focuses on gastric emptying and colonic transit time. Radioactive markers track the movement of food through the digestive system, providing insights into gastrointestinal disorders.
In gastric emptying studies, a meal's liquid and solid...
Assessment of the Rectum and Anus01:25

Assessment of the Rectum and Anus

Evaluating the rectum and anus plays a crucial role in conducting a thorough physical examination of the gastrointestinal system. Although it may be uncomfortable and often embarrassing for the patient, it holds immense diagnostic value, particularly in detecting gastrointestinal diseases and abnormalities. This guide will explain how to perform this assessment using inspection and palpation methods.
Rectal Inspection
Begin by inspecting the perianal and anal areas for color, texture, rashes,...
Drugs Affecting GI Tract Motility: Other Laxatives01:20

Drugs Affecting GI Tract Motility: Other Laxatives

Laxatives are primarily used to alleviate constipation, a common gastrointestinal disorder characterized by infrequent bowel movements and difficulty passing stools. They work by various mechanisms to increase the volume or frequency of bowel movements. The primary modes of action of laxatives include increasing stool bulk, softening the stool, stimulating intestinal motility, and osmotically drawing water into the intestines.
Osmotic or saline laxatives, like magnesium hydroxide or milk of...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Drugs for Treatment of Diarrhea-Predominant IBS01:17

Drugs for Treatment of Diarrhea-Predominant IBS

Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...